HoyleCohen’s ARK Genomic Revolution ETF ARKG Stock Holding History

HoyleCohen’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-5,954	Closed	-$273K	–	261
2022 Q1	$273K	Buy	5,954 +413	+7%	+$19.7K	0.02%	229
2021 Q4	$339K	Buy	5,541 +322	+6%	+$22.3K	0.03%	224
2021 Q3	$390K	Buy	5,219 +325	+7%	+$27.3K	0.04%	202
2021 Q2	$453	Buy	4,894 +525	+12%	+$44.6K	0.04%	191
2021 Q1	$388K	Buy	+4,369	New	+$433K	0.04%	195

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

HoyleCohen's ARKG Position: Q2 2022 in Review

HoyleCohen sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 5,954 shares — an estimated $273K sold.

HoyleCohen first reported a position in ARKG in Q1 2021 and held it in 5 quarters. The position peaked at $390K in Q3 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

HoyleCohen reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
HoyleCohen sold 5,954 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $273K.
HoyleCohen first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 5 quarters.
HoyleCohen's ARK Genomic Revolution ETF position peaked at $390K in Q3 2021.
333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on HoyleCohen's 13F filing for Q2 2022, filed 27 Jul 2022.